These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1781709)

  • 1. [Sensitivity of Pseudomonas mallei to fluoroquinolones and their efficacy in experimental glanders].
    Batmanov VP
    Antibiot Khimioter; 1991 Sep; 36(9):31-4. PubMed ID: 1781709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The efficacy of antibacterial preparations against Pseudomonas mallei in in-vitro and in-vivo experiments].
    Manzeniuk IN; Dorokhin VV; Svetoch EA
    Antibiot Khimioter; 1994; 39(2-3):26-30. PubMed ID: 7979790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sensitivity of Pseudomonas mallei to tetracyclines and their effectiveness in experimental glanders].
    Batmanov VP
    Antibiot Khimioter; 1994 May; 39(5):33-7. PubMed ID: 7857158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro development of fluoroquinolone resistance in the glanders pathogen].
    Stepanshin IuG; Manzeniuk IN; Svetoch EA; Volkovoĭ KI
    Antibiot Khimioter; 1994 Aug; 39(8):30-3. PubMed ID: 7695437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness of treatment of experimental glanders after aerogenic infection].
    Iliukhin VI; Alekseev VV; Antonov IuV; Savchenko ST; Lozovaia NA
    Antibiot Khimioter; 1994; 39(9-10):45-8. PubMed ID: 7695450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the potential of chemotherapy of glanders caused by Pseudomonas mallei strains resistant to sulfanilamides and trimethoprim].
    Manzeniuk IN; Stepanshin IuG; Svetoch EA
    Antibiot Khimioter; 1994 Jul; 39(7):30-4. PubMed ID: 7840707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recovery rate in chemotherapy of glanders].
    Batmanov VP; Iliukhin VI; Lozovaia NA; Iakovlev AT
    Antibiot Khimioter; 1996 May; 41(5):30-4. PubMed ID: 9054315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo activity of ciprofloxacin, ofloxacin, norfloxacin and pipemidic acid against Escherichia coli infections in mice.
    Obana Y; Nishino T
    Drugs Exp Clin Res; 1989; 15(2):53-8. PubMed ID: 2661182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of efficacy of ciprofloxacin and doxycycline against experimental melioidosis and glanders.
    Russell P; Eley SM; Ellis J; Green M; Bell DL; Kenny DJ; Titball RW
    J Antimicrob Chemother; 2000 Jun; 45(6):813-8. PubMed ID: 10837435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of efficacy of modern fluoroquinolones against agent of glanders in experiments in vivo].
    Bondareva TA; Borisevich IV; Kalininskiĭ VB; Bondarev VP; Fomenkov OO
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (3):10-3. PubMed ID: 19623715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinolone therapy in intensive care unit settings.
    Beam TR
    New Horiz; 1993 May; 1(2):187-93. PubMed ID: 7922402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Resistance of Pseudomonas mallei to tetracyclines: assessment of the feasibility of chemotherapy].
    Manzeniuk IN; Manzeniuk OIu; Filonov AV; Stepanshin IuG; Svetoch EA
    Antibiot Khimioter; 1995; 40(11-12):40-4. PubMed ID: 8830639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of fluoroquinolones against chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.
    Tripathi KD; Sharma AK; Valecha N; Biswas S
    Indian J Malariol; 1993 Jun; 30(2):67-73. PubMed ID: 8405596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norfloxacin, ciprofloxacin, and ofloxacin: current clinical roles.
    Hooper DC; Wolfson JS
    Curr Clin Top Infect Dis; 1989; 10():194-240. PubMed ID: 2679694
    [No Abstract]   [Full Text] [Related]  

  • 15. Penetration of topically applied ciprofloxacin, norfloxacin and ofloxacin into the aqueous humor of the uninflamed human eye.
    Akkan AG; Mutlu I; Ozyazgan S; Gok A; Yigit U; Ozuner Z; Senses V; Pekel H
    J Chemother; 1997 Aug; 9(4):257-62. PubMed ID: 9269605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vitro activity of norfloxacin, ofloxacin and ciprofloxacin and other antibiotics in current use against Neisseria gonorrhoeae.
    Melby K; Faegri A
    APMIS; 1989 Apr; 97(4):347-50. PubMed ID: 2497756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro antibiotic susceptibility compliance with efficacy of chemotherapy in infections due to pathogenic Burkholderias].
    Iliukhin VI; Senina TV; Trushkina MN; Shubnikova EV; Antonov IuV; Andropova NV
    Antibiot Khimioter; 2009; 54(7-8):19-23. PubMed ID: 20201399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of ciprofloxacin and norfloxacin in multidrug resistant enteric fever in adults.
    Singh CP; Singh N; Brar GK; Lal G; Kumar H
    J Indian Med Assoc; 1993 Jun; 91(6):156-7. PubMed ID: 8409505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro fluoroquinolone resistance in ocular bacterial isolates].
    Sun XG; Wang ZQ; Li R; Chen L; Jin XY; Luo SY
    Zhonghua Yan Ke Za Zhi; 2003 Mar; 39(3):163-6. PubMed ID: 12880574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro and in vivo activities of norfloxacin, ofloxacin and ciprofloxacin against various mycobacteria].
    Saito H; Sato K; Tomioka H; Watanabe T
    Kekkaku; 1987 May; 62(5):287-94. PubMed ID: 3114537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.